Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
Jyoti Nangalia(Wellcome Sanger Institute), Anthony R. Green(Wellcome/MRC Cambridge Stem Cell Institute), Elli Papaemmanuil(Memorial Sloan Kettering Cancer Center), David Bowen(University of Tennessee Health Science Center), Heather P. Harding(University of Cambridge), Keiran Raine(Wellcome Sanger Institute), Paola Guglielmelli(Azienda Ospedaliero-Universitaria Careggi), Francesca Nice(University of Namur), Ben Robinson(University of Namur), Iñigo Martincorena(Wellcome Sanger Institute), Anna L. Godfrey(University of Namur), Aziz Aziz(University of Namur), Brian J.P. Huntly(Wellcome/MRC Cambridge Stem Cell Institute), David G. Kent(University of York), Amy V. Jones(University of Southampton), Laura Mudie(European Bioinformatics Institute), Kate Hill(University of Namur), John D. Fitzpatrick(University of Namur), Nicholas C.P. Cross(University of Southampton), Karoline Kollmann(University of Veterinary Medicine Vienna), David Bloxham(University of Namur), Patrick Tarpey(Wellcome Sanger Institute), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), E. Joanna Baxter(University of Cambridge), J. Li(University of Namur), Yvonne Silber(University of Namur), Kim Orchard(University of Namur), Michele Leonardo Bianchi(University of Namur), Charles Massie(University of Cambridge), Mel Greaves(Institute of Cancer Research), David Ron(Institute for Medical Research), Mark Maddison(Wellcome Sanger Institute), Stephen J. Loughran(University of Namur), Peter Van Loo(Wellcome Sanger Institute), Christina A. Ortmann(University of Namur), Jonathan Hinton(Wellcome Sanger Institute), Gunes Gundem(Memorial Sloan Kettering Cancer Center), Cathy MacLean(University of Namur), Calum T Goudie(University of Namur), Daniel Jones(University of Namur), Sheral Raina Tauro(University of Namur), Stuart McLaren(European Bioinformatics Institute), Jon W. Teague(Wellcome Sanger Institute), Clodagh Keohane(University of Namur), Adam P. Butler(Wellcome Sanger Institute), D. Dimitropoulou(University of Namur), Edward Avezov(Tel Aviv University), Sarah O’Meara(Wellcome Sanger Institute), Ming‐Qing Du(MRC Laboratory of Molecular Biology), David C. Wedge(University of Manchester)
Cited by 1,734
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k